A total of 32 percutaneous renal biopsies were examined from patients with rheumatoid arthritis. The renal biopsies in these patients present a very heterogeneous picture; there were 9 cases of chronic interstitial nephritis and 4 cases of amyloidosis. In one patient whose renal biopsy showed glomerulitis, a muscle biopsy resulted in a diagnosis of polyarteritis nodosa. 11 biopsies showed a normal histology, and 6 showed arteriosclerosis of the small arteries. Finally, 1 patient showed so-called membranous glomerulonephritis; this may have been the coincidental presence of 2 diseases. We were unable to confirm the existence of a vascular rheumatoid lesion, as previously reported in the litterature. Employing a technique which permitted a quantitative evaluation of the nuclear distribution in the glomeruli, this distribution was examined in the biopsies from 28 patients with rheumatoid arthritis and in 11 patients with gallstones, but with normal renal function and normal blood pressure. The presence of a glomerular hypercellularity in rheumatoid arthritis, as has previously been claimed was not confirmed. It was likewise not possible to demonstrate local hypercellularity in the glomeruli of patients with rheumatoid arthritis and normal renal biopsies.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.